Today: GHIAA's Julia Barnes-Weise joins international experts examining voluntary licensing frameworks.
11AM Chile / 3PM Europe
Register: https://us06web.zoom.us/meeting/register/2kZ5mCBWTTmf_CJGZkUqVg#/registration
Today: GHIAA's Julia Barnes-Weise joins international experts examining voluntary licensing frameworks.
11AM Chile / 3PM Europe
Register: https://us06web.zoom.us/meeting/register/2kZ5mCBWTTmf_CJGZkUqVg#/registration
Feb 3: GHIAA's Julia Barnes-Weise joins experts examining how voluntary licensing frameworks deliver equitable access. Exploring incentive mechanisms that translate policy into enforceable contracts.
Register: https://us06web.zoom.us/meeting/register/2kZ5mCBWTTmf_CJGZkUqVg
#GlobalHealth
New on the MAPGuide: Protalix BioTherapeutics & Fiocruz (Brazil) enter a technology transfer and supply agreement for enzyme replacement therapy for Gaucher Disease.
π https://ghiaa.org/mapguide-home/search-results/?qs=Protalix+-+Fiocruz%2C+Gaucher+Disease+Therapy+Technology+Transfer+Agreement
π Have you checked out what we read last month?
European Health and Digital Executive Agency (HaDEA) #EU4Health calls on crisis preparedness are open until Dec 4, 2025
Discover more & subscribe β https://www.linkedin.com/pulse/policies-impact-september-2025-global-healthcare-innovation-allia-8mulf
New on the MAPGuide π
Harvard University & Tectonic Therapeutic sign a license covering patent rights and discovery materials.
Read more here
π https://ghiaa.org/mapguide-home/search-results/?qs=Tectonic+Therapeutic+License+Agreement
π₯ Couldnβt attend live? Catch the recording!
Our ED Julia Barnes-Weise joined Ana Ayala, Ximena Benavides Reverditto & Jacob Madden at the National Vaccine Law Conference to discuss how global health security can serve more diverse communities.
πhttps://www.youtube.com/watch?v=agMtNZO5wl4
September Newsletter just dropped!
Inside: Juliaβs take on global health convenings, new MAPGuide entries, insights from the Vaccine Law Conference + recording, and a warm team welcome.
π https://www.linkedin.com/pulse/policies-impact-september-2025-global-healthcare-innovation-allia-8mulf
#GHIAA
Our May newsletter features two new MAPGuide agreements and a highlight of our Equitable Access Glossary!
www.linkedin.com/pulse/polici...
health-economictimes-indiatimes-com.cdn.ampproject.org/c/s/health.e...
In this edition of Policies to Impact, we introduce you to GHIAA board member Magali Poinot and reintroduce our Equitable Access Pyramid!
www.linkedin.com/pulse/polici...
New on the MAPGuide: IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
Read the agreement here: lnkd.in/e8HUWVNm
Explore the MAPGuide here: lnkd.in/d6ZcxXN
New on the MAPGuide: Public Health England, Model Fast Track Testing & Evaluation Agreement
Read the agreement here: ow.ly/Vpok50UY6iM
Explore the MAPGuide here: ow.ly/Gm9Q50UY6iL
New on the MAPGuide: PTC Therapeutics - Roche - Spinal Muscular Atrophy Foundation, Spinal Muscular Atrophy License and Collaboration Agreement
Read the agreement here: lnkd.in/esQqfEwc
Explore the MAPGuide here: lnkd.in/d6ZcxXN
Our February 2025 Linkedin newsletter is now live: www.linkedin.com/pulse/polici...
New on the MAPGuide: MPP β Biovac, mRNA Vaccine Technology Transfer Agreement
Read the agreement here: ow.ly/sM5w50UY5we
Explore the MAPGuide here: ow.ly/Grb850UY5wf
New on the MAPGuide: Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement.
Read the agreement here: ow.ly/k6nS50UY5FW
Explore the MAPGuide here: lnkd.in/d6ZcxXN
If you're interested in more content from GHIAA, please make sure you're following us over on LinkedIn!
www.linkedin.com/company/glob...
New on the MAPGuide: This project aims to reduce supply uncertainty and lower the cost of artemisinin for ACTs, particularly in developing countries. Read the agreement here: ghiaa.org/mapguide-hom...
The MAPGuide is a tool for accessing and exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products. Our extended tutorial introduces you to all the functionality of the MAPGuide - check it out!
www.youtube.com/watch?v=PVPX...
βSome people say this may create panic,β said Tedros Adhanom Ghebreyesus, WHO director-general. βNo. History has taught us that we must anticipate new threats. Failing to prepare leaves the world prepared to fail.β
www.worldfinance.com/special-repo...
"The US is not the only country facing uncertainty over government funding for science. Here is a look at science and technology spending in other major nations and regions:"
cen.acs.org/policy/resea...
GHIAA has published comments on the new NIH Intramural Research Program Access Planning Policy: ghiaa.org/mapguide-hom...
The US is not the only country facing uncertainty over government funding for science. Here is a look at science and technology spending in other major nations and regions. cen.acs.org/policy/resea... #chemskyπ§ͺ #scinews
Subscribe to our quarterly newsletter for periodic updates from GHIAA delivered straight to your inbox: ghiaa.org/home/newslet...
We hope that our MAPGuide resources will help support the development of equitable access plans. ghiaa.org/mapguide-home/
We congratulate the NIH on taking this step towards ensuring equitable access to products from NIH-owned patents and look forward to following the implementation of this Policy.
osp.od.nih.gov/policies/inn...
"The result of this, said Pai, is that Africans are least represented in global health organizations, boards, conferences, and publications."
www.nature.com/articles/d44...